Q4 FY23 Quarterly Report and Appendix 4C: Net Cash Used in Operating Activities Down 56% YoY to Record Low SmartNews
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 Medical Device Investing
CABTREO Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Pharmaceutical Investing
Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules Psychedelics Investing
